TaiMed Biologics Overview

  • Founded
  • 2007
Founded
  • Status
  • Public
  • Employees
  • 23
Employees
  • Stock Symbol
  • 4147
Stock Symbol
  • Share Price
  • $2.54
  • (As of Friday Closing)

TaiMed Biologics General Information

Description

TaiMed Biologics Inc is a Taiwan-based biotechnology company. It is engaged in the discovery, development, and delivery of medicines primarily for HIV in Taiwan. It capitalizes on its intellectual, extensive expertise, and management resources to develop a strong health-care product pipeline that benefits patients, rewards investors, and propels to prominence in the biotechnology industry. The company's products pipeline includes TMB-355, TMB-365, TMB-Bispecific, VRC07-523LS, and others.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Stock Exchange
ROCO
Primary Office
  • 18F-1. No.3, Yuan-Qu Street
  • Nangang District
  • Taipei, 115-03
  • Taiwan
+886 02 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TaiMed Biologics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.54 $2.59 $2.12 - $4.38 $641M 252M 620K -$0.01

TaiMed Biologics Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 665,593 732,555 781,717 1,280,784
Revenue 19,850 24,545 22,799 7,990
EBITDA 1,578 (1,628) (16,197) (8,578)
Net Income (3,559) (6,227) (18,726) (10,664)
Total Assets 176,142 186,295 157,955 156,657
Total Debt 23,763 20,408 1,135 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

TaiMed Biologics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore TaiMed Biologics‘s full profile, request access.

Request a free trial

TaiMed Biologics Executive Team (6)

Name Title Board Seat Contact Info
James Chang President & Chief Executive Officer
Jack Chen Financial ontroller
Qiankun Lin Advisor
Ruizhu Li Advisor
Xiaoling Chen Advisor
You’re viewing 5 of 6 executive team members. Get the full list »

TaiMed Biologics Board Members (6)

Name Representing Role Since
Lupin Zhou Self Board Member 000 0000
Mingjin Chen Self Board Member 000 0000
Suhuai Ren Self Board Member 000 0000
Zhaolian Huang Self Board Member 000 0000
Zhiquan Chen Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

TaiMed Biologics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TaiMed Biologics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore TaiMed Biologics‘s full profile, request access.

Request a free trial